Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults
Clinical trial NCT03245619 · TERMINATED
Trial details
- NCT number
- NCT03245619
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-22
- Primary completion
- 2018-05-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.